We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
International Biotechnology Trust Plc | LSE:IBT | London | Ordinary Share | GB0004559349 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
9.00 | 1.46% | 627.00 | 622.00 | 630.00 | 628.00 | 626.00 | 626.00 | 42,831 | 16:35:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | 12.06M | 6.81M | 0.1733 | 36.24 | 246.92M |
TIDMIBT
RNS Number : 5044A
Intl. Biotechnology Trust PLC
24 March 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ------------------------------------------------------------------------------------------------- 1. Identity of the issuer or International Biotechnology the underlying issuer Trust plc of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------- ---------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ---------------------------------------------------------------- ------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------- ------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------- ------------------------------- An event changing the breakdown of voting rights ---------------------------------------------------------------- ------------------------------- Other (please specify): --------------------------------------------------------- ----- ------------------------------- 3. Full name of person(s) Lazard Asset Management LLC subject to the notification obligation: (iii) ----------------------------------------------------------- ------------------------------------ 4. Full name of shareholder(s) JP Morgan Chase - SWIFT (if different from 3.):(iv) Mellon Trust Northern Trust Co State Street Bank - Custodian ETC State Street Bank - Master Tr - ETC State Street Bank - Custody Master Trust ----------------------------------------------------------- ------------------------------------ 5. Date of the transaction 23 March 2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ------------------------------------ 6. Date on which issuer 24 March 2017 notified: ----------------------------------------------------------- ------------------------------------ 7. Threshold(s) that is/are Decrease from 21% to 20% crossed or reached: (vi, vii) ----------------------------------------------------------- ------------------------------------ 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- ---------------------------------- ------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ------------- ---------------- ---------------- -------------- ------------------------ ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ------------ ------------ -------------- --------- ------------- ------------ ----------- GB0004559349 7,904,509 7,879,509 20.985% ---------------- ---------------- -------------- --------- ------------- ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- -------------- -------------------------------- -------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- -------------- -------------- ---------------- -------------------------- ----------------------- Nominal Delta --------------- -------------- -------------- ---------------- -------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------------- ----------------------------------------------------------------- 7,879,509 20.985% --------------------------------------------------- ----------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------------------------------- Lazard Asset Management LLC controls all the voting rights held of this issuer. Proxy Voting: --------------------------------------------------------------------------------------- 10. Name of the proxy holder: N/A ------------------------------------------------------- ------------------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------- ------------------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------- ------------------------------ 13. Additional information: ------------------------------------------------------- ------------------------------ 14. Contact name: Legal & Compliance Department ------------------------------------------------------- ------------------------------ 15. Contact telephone number: 0207 448 2085 ------------------------------------------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUSASRBOAOUAR
(END) Dow Jones Newswires
March 24, 2017 10:15 ET (14:15 GMT)
1 Year International Biotechnol... Chart |
1 Month International Biotechnol... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions